MAIN TRANSACTION TERMS Reverse share split through the exchange of one thousand (1,000) existing shares with a par value of one euro cent (€0.01) for one (1) new share to be issued with a par value of ten euros (€10.00) Period of the reverse share split exchange: from February 20th, 2024 to March 21st, 2024 inclusive Effective date of reverse share split (listing of new shares): March 22nd, 2024 Suspension of the deferred settlement service for existing shares: from February 27th, 2024 PUTEAUX, France, February 20, 2024--(BUSINESS WIRE)--Regulatory News: ORPEA S.A. (the "Company") (Paris:ORP) announces today the implementation of the reverse share split of all outstanding shares of the Company and gives details of the terms of the operation (the "Reverse Share Split"). In accordance with the notice of the Reverse Share Split in the Bulletin des Annonces Légales Obligatoires (BALO) on February 5th, 2024 and following the announcement of the details and expected timetable of the Reverse Share Split by the Company in the press release dated February 5th, 2024, the Reverse Share Split will start today in accordance with the terms set out below. It should be remembered that following settlement-delivery of the share capital increase with shareholders' preferential subscription rights, having been the subject of a prospectus approved by the AMF on January 17th, 2024 under number 24-006, which took place on February 15th, 2024, the Company's share capital now amounts to EUR 1,591,917,031.11, divided into 159,191,703,111 ordinary shares with a par value of one euro cent (0.01) each. The Reverse Share Split will result in the allocation of one (1) new ordinary share to be issued with a par value of ten (10.00) euros (the "New Shares") for one thousand (1,000) existing ordinary shares with a par value of one euro cent (0.01) each (the "Existing Shares"), and the division by one thousand (1,000) of the number of outstanding shares of the Company's share capital as of today, i.e. a total of 159,191,703,111 shares with a par value of one euro cent (0.01) each. It should be remembered that the Reverse Share Split is a purely technical exchange transaction with no direct impact on the total value of the Company's shares held by each shareholder. A list of Frequently Asked Questions (FAQ) about the Reverse Share Split is available at the following link. Definitive terms and conditions of the Reverse Share Split: Date of the beginning of the Reverse Share Split: February 20th, 2024. Basis of the Reverse Share Split: exchange of one thousand (1,000) Existing Shares with a par value of one euro cent (0.01) for one (1) New Share with a par value of ten (10.00) euros. Number of Existing Shares subject to the Reverse Share Split: 159,191,703,111 shares, each with a par value of 0.01 euros. Number of New Shares to be issued as a result of the Reverse Share Split: 159,191,703 shares with a par value of 10 euros each. Reverse Share Split exchange period: thirty (30) days from the date of commencement of the Reverse Share Split, i.e. from February 20th, 2024 to March 21st, 2024 inclusive. Whole shares: the conversion of Existing Shares into New Shares will be carried out automatically (procédure d’office). Fractional shares: shareholders who do not hold a number of Existing Shares corresponding to a whole number of New Shares must personally purchase or sell fractional Existing Shares, in order to obtain a number of shares that is a multiple of 1,000, up to and including March 21st, 2024 inclusive. After this date, any shares that could not be allocated individually and corresponding to fractional shares will be sold in accordance with the terms and conditions set out in Article R. 228-12 of the French Commercial Code and in accordance with market practice. Existing shares that have not been consolidated will be delisted at the end of the Reverse Share Split period. Voting rights: the New Shares will immediately carry double voting rights, provided they are held in registered form, if, at the date of the Reverse Share Split of the Existing Shares from which they are issued, each of these Existing Shares carried double voting rights. At the end of the Reverse Share Split period, shares that have not been consolidated will lose their voting rights and will no longer be included in the calculation of the quorum, and their rights to future dividends will be suspended. Centralization: all transactions relating to the Reverse Share Split will be carried out by Société Générale Securities Services, 32 rue du Champ de Tir, CS 30812, 44308 Nantes Cedex 3, appointed as agent for the centralization of the Reverse Share Split. Pursuant to Articles L. 228-6-1 and R. 228-12 of the French Commercial Code, at the end of a period of 30 days from March 22nd, 2024, the New Shares that could not be allocated individually and corresponding to fractional shares will be sold on the stock market by the account holders, and the proceeds of the sale will be allocated in proportion to the fractional shares of the holders of these shares. Existing Shares subject to the Reverse Share Split will be admitted to trading on Euronext Paris under ISIN code FR0000184798 until March 21st, 2024, the last day of trading. New Shares resulting from the Reverse Share Split will be admitted to trading on Euronext Paris from March 22nd, 2024, the first day of trading, under the new ISIN code FR001400NLM4. Adjustment of the exercise ratio of free shares awarded: the Board of Directors has granted full powers to the Chief Executive Officer, in order to preserve the rights of holders of free shares awarded, to adjust the exercise ratio of free shares awarded following the Reverse Share Split, if necessary, to take account of the impact of the said Reverse Share Split on the situation of holders of free shares awarded. Suspension of the eligibility of the Existing Shares for the deferred settlement service: until the close of trading on February 26th, 2024, the Existing Shares will remain eligible for the deferred settlement service (the "DSS") and may therefore continue to be subject to deferred settlement. As from February 27th, 2024, the Existing Shares will no longer be eligible for the DSS and will have to be settled in cash until their last trading day, i.e. March 21st, 2024. As from March 22nd, 2024, the date of their admission to listing, the New Shares will be eligible for the DSS. Indicative timetable: February 5th, 2024 Publication of the notice of the Reverse Share Split in the Bulletin des Annonces Légales Obligatoires February 20th, 2024 Start of Reverse Share Split operations From February 27th, 2024 Suspension of the DSS for the Existing Shares February 20th, 2024 to March 21st, 2024 inclusive Possibility for shareholders to buy and sell shares in order to obtain a number without fractional shares March 21st, 2024 Last day of trading of Existing Shares March 22nd, 2024 Listing of the New Shares * * * About ORPEA ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 20 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 267,000 patients and residents each year. https ://www.orpea-group.com/ Since December 2023, the ORPEA Group has been 50.2% owned by Caisse des Dépôts, CNP Assurances, MAIF and MACSF Épargne Retraite. ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120 and CAC Mid 60 indices. View source version on businesswire.com: https://www.businesswire.com/news/home/20240219882598/en/ Contacts Investor Relations ORPEA Benoit Lesieur Investor Relations Director [email protected] Toll-free number for shareholders: 0 805 480 480 Investor Relations NewCap Dusan Oresansky Tel.: 01 44 71 94 94 [email protected] Press Relations ORPEA Isabelle Herrier-Naufle Investor Relations Director Tel.: 07 70 29 53 74 [email protected] Image7 Charlotte Le Barbier // Laurence Heilbronn 06 78 37 27 60 – 06 89 87 61 37 [email protected] [email protected]
ORPEA Announces the Implementation of the Reverse Share Split of Its Outstanding Shares
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...